Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
about
A pharmaceutical industry perspective on the economics of treatments for alcohol and opioid use disordersHow to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3).Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data.Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications.Practical issues in handling data input and uncertainty in a budget impact analysis.Health economic assessment: a methodological primerHealth and economic impact of rotavirus vaccination in GAVI-eligible countriesBudget impact analysis of switching to digital mammography in a population-based breast cancer screening program: a discrete event simulation model.Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries.The economic burden to medicare of stroke events in atrial fibrillation populations with and without thromboprophylaxis.Adoption of Biosimilar Infliximab for Rheumatoid Arthritis, Ankylosing Spondylitis, and Inflammatory Bowel Diseases in the EU5: A Budget Impact Analysis Using a Delphi PanelEconomic and organizational sustainability of a negative-pressure portable device for the prevention of surgical-site complications.Protocol for an economic evaluation alongside the University Health Network Whiplash Intervention Trial: cost-effectiveness of education and activation, a rehabilitation program, and the legislated standard of care for acute whiplash injury in OntarCurrent Status and Future Prospects of Clinical Psychology: Toward a Scientifically Principled Approach to Mental and Behavioral Health Care."Budget impact analyses": a practical policy making tool for drug reimbursement decisionsBudget impact analysis of antiretroviral less drug regimen simplification in HIV-positive patients on the Italian National Health ServiceOrphan drugs expenditure in the Netherlands in the period 2006-2012.Expanded HIV screening in the United States: what will it cost government discretionary and entitlement programs? A budget impact analysis.Blended vs. face-to-face cognitive behavioural treatment for major depression in specialized mental health care: study protocol of a randomized controlled cost-effectiveness trial.Economic benefits of safety-engineered sharp devices in Belgium - a budget impact modelDutasteride plus tamsulosin fixed-dose combination first-line therapy versus tamsulosin monotherapy in the treatment of benign prostatic hyperplasia: a budget impact analysis in the Greek healthcare setting.Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analystsPopulation-level cost-effectiveness of implementing evidence-based practices into routine care.Using resource modelling to inform decision making and service planning: the case of colorectal cancer screening in Ireland.Budget impact analysis of chronic kidney disease mass screening test in Japan.The economic burden of diabetes in India: a review of the literatureA tutorial on sensitivity analyses in clinical trials: the what, why, when and how.Annual biologic treatment cost for new and existing patients with moderate to severe plaque psoriasis in Greece.Budget impact analysis of first-line treatment with pazopanib for advanced renal cell carcinoma in Spain.Establishing common cost measures to evaluate the economic value of patient navigation programs.A cluster randomized trial for the implementation of an antibiotic checklist based on validated quality indicators: the AB-checklistHealth economic consequences of reducing salt intake and replacing saturated fat with polyunsaturated fat in the adult Finnish population: estimates based on the FINRISK and FINDIET studiesA budget impact analysis of rapid human immunodeficiency virus screening in Veterans Administration emergency departmentsCost effectiveness of interpersonal community psychiatric treatment for people with long-term severe non-psychotic mental disorders: protocol of a multi-centre randomized controlled trialImplementation and evaluation of the VA DPP clinical demonstration: protocol for a multi-site non-randomized hybrid effectiveness-implementation type III trial.Pre-eclampsia Diagnosis and Treatment Options: A Review of Published Economic Assessments.Controlled Ovarian Stimulation with recombinant-FSH plus recombinant-LH vs. human Menopausal Gonadotropin based on the number of retrieved oocytes: results from a routine clinical practice in a real-life population.The impact of the 'Better Care Better Value' prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimentaCost effectiveness and budgetary impact of the Boston University approach to Psychiatric Rehabilitation for societal participation in people with severe mental illness: a randomised controlled trial protocolTreatment Options for Age-Related Macular Degeneration: A Budget Impact Analysis from the Perspective of the Brazilian Public Health System
P2860
Q27000732-E956514C-EE69-4746-B03B-6274C815F959Q30241967-92696625-C19A-4305-AEB7-9EAEBB84527FQ30670881-1F6BA3B6-32CF-49D4-B903-87C91C55A699Q33395099-DF4013C8-924F-4CB0-BB63-41BA61E85705Q33549234-64C83695-CECC-4FDC-BF19-044BF5846C54Q33566896-8896564D-F0CA-4257-8913-5B83FDC11ED5Q33578406-B60A0203-B389-4F11-BFB5-E2E539A878D8Q33617993-FABF81F2-7019-436E-90A3-DF31E39D194EQ33713261-D4440DF2-EF8B-4F71-9254-8C68A8477A77Q33731173-0D735F74-3B63-4F39-A22B-7B8BC0359A3AQ33740641-7B48DB7B-58D4-4CF9-AD7E-14BA9B7850F6Q33806856-6D99CA7C-5AA2-40F1-AB3F-A85632B1FE4FQ33973056-C3BF5F39-3CD2-4FA5-BA39-1FE7218A2586Q34145173-6D96B547-D37C-4393-B71F-8F67E53BD2B6Q34256272-DC050459-250E-426C-BAC8-4B7FDB2E46A8Q34273315-2441331B-0EA6-4CD9-B217-94CF299BE514Q34333608-F96848FF-DC05-4B91-92C0-38EAB7453B82Q34393599-C3D65F8F-F7F2-48CA-8F25-6446F49A61D2Q34402083-E525CACF-137F-485F-AAE1-F48DE527D556Q34465451-47B2045B-AFA6-4645-8478-CFD18054A57DQ34539001-C3C1DC3A-7338-41A1-973D-EAA5A242E413Q34567701-EDD1D3AE-3597-4924-80E3-4EE7EB9CF69AQ34623043-D391F52F-ADAD-4083-ABCE-D20A00F03779Q34627515-AB95B1CA-3639-4885-99FE-F8066DE95C91Q34737206-20F763F7-4CB5-4AB8-AF66-743767DBDB1DQ34789055-4589E504-9538-4B6F-B688-8615CFE0B2D0Q34819923-BF4D93FC-A2A2-4DB4-ADEE-EAC5ECA1FA68Q34944668-0073E499-83FC-4B01-A95A-89B6644657D5Q34978199-5C8B3DB6-6D45-4F05-AC39-68FD624A302FQ35149948-0A73F868-5B49-4182-B9AA-4B580DFD147BQ35204182-CB5C8F38-2BEF-4C46-A5BB-0EA38066DC6CQ35294920-36A7967D-A61B-4E1C-AF87-924D1CD8DC13Q35478701-4C16E8CE-DFA1-4E71-982D-02DDFEB90797Q35577141-60262AFD-4890-4DE0-AC98-6720D9CD09FAQ35601179-21DF95A0-D096-4BFB-A651-DD879CE08D76Q35655056-2EED9F76-5532-487E-B79D-351018B059E5Q35713241-9DB0F547-D00C-4977-80EA-6594808705FFQ35770269-1DCF80EA-DD28-4E9B-8635-318196B55C71Q35776582-5D6EEB38-C9DB-4372-86C5-518B1463B3B3Q35803263-07C9D491-28B1-42E1-B961-51DFED47E641
P2860
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Principles of good practice fo ...... tices--budget impact analysis.
@en
type
label
Principles of good practice fo ...... tices--budget impact analysis.
@en
prefLabel
Principles of good practice fo ...... tices--budget impact analysis.
@en
P2093
P1433
P1476
Principles of good practice fo ...... ctices--budget impact analysis
@en
P2093
Ewa Orlewska
John Watkins
Josephine A Mauskopf
Lieven Annemans
Mark Nuijten
Paul Trueman
Sean D Sullivan
P304
P356
10.1111/J.1524-4733.2007.00187.X
P577
2007-09-01T00:00:00Z